These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3950904)
1. 5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues. Glennon RA; McKenney JD; Lyon RA; Titeler M J Med Chem; 1986 Feb; 29(2):194-9. PubMed ID: 3950904 [TBL] [Abstract][Full Text] [Related]
2. N-methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Glennon RA; Titeler M; Seggel MR; Lyon RA J Med Chem; 1987 May; 30(5):930-2. PubMed ID: 3572981 [TBL] [Abstract][Full Text] [Related]
3. 5-HT1 and 5-HT2 binding characteristics of some quipazine analogues. Glennon RA; Slusher RM; Lyon RA; Titeler M; McKenney JD J Med Chem; 1986 Nov; 29(11):2375-80. PubMed ID: 3783595 [TBL] [Abstract][Full Text] [Related]
4. Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. Glennon RA; Raghupathi R; Bartyzel P; Teitler M; Leonhardt S J Med Chem; 1992 Feb; 35(4):734-40. PubMed ID: 1542100 [TBL] [Abstract][Full Text] [Related]
5. A preliminary investigation of the psychoactive agent 4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse. Glennon RA; Titeler M; Lyon RA Pharmacol Biochem Behav; 1988 Jul; 30(3):597-601. PubMed ID: 3211969 [TBL] [Abstract][Full Text] [Related]
6. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand. Titeler M; Lyon RA; Davis KH; Glennon RA Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239 [TBL] [Abstract][Full Text] [Related]
7. 1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT(2A) serotonin receptor affinity and antagonist character. Rangisetty JB; Dukat M; Dowd CS; Herrick-Davis K; DuPre A; Gadepalli S; Teitler M; Kelley CR; Sharif NA; Glennon RA J Med Chem; 2001 Sep; 44(20):3283-91. PubMed ID: 11563927 [TBL] [Abstract][Full Text] [Related]
8. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist. Pranzatelli MR Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895 [TBL] [Abstract][Full Text] [Related]
9. Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist. Ismaiel AM; De Los Angeles J; Teitler M; Ingher S; Glennon RA J Med Chem; 1993 Aug; 36(17):2519-25. PubMed ID: 8355253 [TBL] [Abstract][Full Text] [Related]
10. 1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists. Dowd CS; Herrick-Davis K; Egan C; DuPre A; Smith C; Teitler M; Glennon RA J Med Chem; 2000 Aug; 43(16):3074-84. PubMed ID: 10956215 [TBL] [Abstract][Full Text] [Related]
11. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration. Owens MJ; Knight DL; Ritchie JC; Nemeroff CB J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213 [TBL] [Abstract][Full Text] [Related]
12. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). Shannon M; Battaglia G; Glennon RA; Titeler M Eur J Pharmacol; 1984 Jun; 102(1):23-9. PubMed ID: 6479216 [TBL] [Abstract][Full Text] [Related]
14. Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Glennon RA; Bondarev ML; Khorana N; Young R; May JA; Hellberg MR; McLaughlin MA; Sharif NA J Med Chem; 2004 Nov; 47(24):6034-41. PubMed ID: 15537358 [TBL] [Abstract][Full Text] [Related]
15. A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors. Seggel MR; Yousif MY; Lyon RA; Titeler M; Roth BL; Suba EA; Glennon RA J Med Chem; 1990 Mar; 33(3):1032-6. PubMed ID: 2308135 [TBL] [Abstract][Full Text] [Related]
16. 5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin. Ismaiel AM; Titeler M; Miller KJ; Smith TS; Glennon RA J Med Chem; 1990 Feb; 33(2):755-8. PubMed ID: 2299641 [TBL] [Abstract][Full Text] [Related]
17. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors. Lyon RA; Davis KH; Titeler M Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649 [TBL] [Abstract][Full Text] [Related]
18. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. Glennon RA; Young R; Rosecrans JA Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740 [TBL] [Abstract][Full Text] [Related]
19. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor. Branchek T; Adham N; Macchi M; Kao HT; Hartig PR Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697 [TBL] [Abstract][Full Text] [Related]
20. Demethyl analogues of psychoactive methoxyphenalkylamines: synthesis and serotonin receptor affinities. Glennon RA; Liebowitz SM; Leming-Doot D; Rosecrans JA J Med Chem; 1980 Sep; 23(9):990-4. PubMed ID: 7411554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]